The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.

Corti, the leading infrastructure layer for building clinical-grade AI in healthcare, today announced the launch of FactsRtm, a breakthrough real-time agentic reasoning system for clinical ...

The Apache Software Foundation (ASF) has announced that two promising projects, Apache Gravitino and Apache StormCrawler, ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...

We recently published a list of 10 Stocks Are Dominating Like Wall Street Titans. In this article, we are going to take a ...

We recently published a list of 15 Stocks That Stole The Show Last Week. In this article, we are going to take a look at ...

Boltz-2's development was led by the Boltz team at MIT under the supervision of Professors Regina Barzilay and Tommi Jaakkola alongside a team of researchers from MIT and Recursion. For more ...

Apple debunks the hype around A.I. with a study showing that models struggle with complex reasoning, despite advanced ...

The Singularity, if it comes, will mark the end of human authorship in the strictest sense. From that point on, the story of civilization will be co-written—by us, and by minds we have created.

Biosensors are devices used to detect the presence or concentration of a biological analyte, such as a biomolecule, a biological structure ... insertion and sensor application, showing the ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. We analyzed 27 popular budgeting apps and evaluated them ...